Research Report University Hospital for clinical assessment EFC11570

Abstract

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Alirocumab (SAR236553/REGN727) on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome

Keywords

• Acute Coronary Syndrome
• Alirocumab (SAR236553/REGN727)